IL37 and fibrosarcoma: Recently, it has been demonstrated that IL-37 suppresses tumor progression, including cervical cancer [9], fibrosarcoma [10], hepatocellular carcinoma [11], lung cancer [12, 13], renal cell carcinoma[14] and breast cancer [15].